Characterizing Deamidation and Oxidation in Adalimumab with Low pH Peptide Mapping and Middle-Up Mass Spec Analysis.
ASMS Sanibel Conference 2016
![](/sites/default/files/resources/Quality-Assistance-Poster-Characterizing-Deamidation-and-Oxidation-in-Adalimumab-with-Low-pH-Peptide-Mapping-and-Middle-Up-Mass-Spec-Analysis_0.jpg)
Non-enzymatic chemical modifications such as deamidation, oxidation and disulfide bond scrambling can affect the stability and efficacy of biotherapeutic proteins.